NCT01644903 Proteogenomic Monitoring and Assessment of Liver Transplant Recipients
| NCT ID | NCT01644903 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Northwestern University |
| Condition | Liver Transplant |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2010-04 |
| Primary Completion | 2030-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2010-04 with a primary completion date of 2030-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is being done to test blood, urine and tissue samples to see if this can help decide if CKD (Chronic Kidney Disease), AR (Acute Rejection) and HCV (Hepatitis C Virus) can be identified in its early stages. CKD damage to the kidneys, AR and HCV all lower the body's ability to function properly. Early detection of these conditions could assist with successful treatment and possibly lead to less repeat organ transplants.
Eligibility Criteria
Inclusion Criteria: 1. Male and female recipients of all races, ≥18 years of age. 2. Patients undergoing primary or subsequent living or deceased donor liver transplantation. 3. Subject and/or guardian must be able to provide informed consent. 4. Subject and/or guardian must be able to comply with the study protocol. Exclusion Criteria: 1\. Inability or unwillingness of a participant and/or guardian to provide informed consent.
Contact & Investigator
Misael Villegas, BA
✉ misael.villegas@northwestern.eduJosh Levitsky, MD
PRINCIPAL INVESTIGATOR
Northwestern University
Frequently Asked Questions
Who can join the NCT01644903 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Liver Transplant. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT01644903 currently recruiting?
Yes, NCT01644903 is actively recruiting participants. Contact the research team at misael.villegas@northwestern.edu for enrollment information.
Where is the NCT01644903 trial being conducted?
This trial is being conducted at Chicago, United States.
Who is sponsoring the NCT01644903 clinical trial?
NCT01644903 is sponsored by Northwestern University. The principal investigator is Josh Levitsky, MD at Northwestern University. The trial plans to enroll 1,000 participants.